sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleasePharmaceuticals & Biotech

Mental Health Market Forecast to USD 23.74 billion by 2034, Growing 13.24% a Year

North America leads with 40% of 2025 revenue, while Stress Management grows fastest at 14.4% across the forecast period.

PUNE, INDIA — 21 SEPTEMBER 2026CONTRIVE DATUM INSIGHTS

From USD 7.6 billion in 2025 to USD 23.74 billion in 2034, a 13.24% compound annual rate.

40% of 2025 revenue (USD 3.04 billion) is generated in North America.

Fastest growth: Stress Management at 14.4% a year.

Depression and Anxiety Management leads application type with 33.95% of 2025 revenue.

The global mental health market was valued at USD 7.6 billion in 2025. The market is projected to grow from USD 8.78 billion in 2026 to USD 23.74 billion by 2034, exhibiting a compound annual growth rate of 13.24% during the forecast period. Contrive Datum Insights presents this information in its report titled "Mental Health Market Size, Share & Industry Analysis, By Application type (Depression and Anxiety Management, Meditation Management, Stress Management, Wellness Management, Others), Platform type (iOS, Android, Others), Business model (Subscription-Based, Freemium, Advertising-Based), End user (Individual and Consumer, Enterprise and Employers, Healthcare Providers and Payers), Age group (Adults, Adolescents and Teenagers, Geriatric), and Regional Forecast, 2026-2034".

Mental health apps are consumer and provider-facing software applications, delivered on iOS and Android devices, that support psychological wellbeing through structured programs for conditions such as anxiety and depression as well as everyday stress and general wellness. They range from self-guided meditation and mood-tracking tools to programs that connect a user with a licensed therapist or coach, and are used directly by consumers, purchased in bulk by employers as an employee benefit, or referred by a clinician or health plan as part of a treatment pathway.

Rising diagnosed prevalence of anxiety and depression

Rising diagnosed prevalence of anxiety and depression is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 13.24% a year, the application type lines exposed to it move fastest: Stress Management compounds at 14.4%, taking its share of revenue from 20% to 21.99% and its value from USD 1.52 billion to USD 5.22 billion.

Where the forecast could be beaten: the bull case assumes employer and insurer benefit adoption accelerates faster than the base case in the United States and United Kingdom, and that smartphone and data-plan penetration in Asia Pacific reaches a larger share of the population sooner. The study puts that case at USD 28.01 billion in 2034, against USD 23.74 billion in the base.

The downside is specific. The bear case assumes employer benefit budgets tighten, freemium-to-paid conversion slows as competition among free alternatives increases, and stricter app store privacy rules raise the cost of acquiring new paying users, and 2034 revenue lands at USD 20.42 billion. Depression and Anxiety Management is the drag, 33.95% of the 2025 base compounding at 12.46% while the market runs at 13.24%.

Key Players Compete on Depression and Anxiety Management Volume and Stress Management Growth

Suppliers here are separated by application type, not by geography. The incumbent position is Depression and Anxiety Management: 33.95% of 2025 revenue, USD 2.58 billion, and still 32.02% in 2034. The contested position is Stress Management at 14.4% growth. Few suppliers hold both, which is why a market of USD 7.6 billion supports as many participants as it does.

Further Report Findings

SegmentLed 2025 byShare & valueFastest-growing
Platform typeAndroid55% · USD 4.18 billion
Business modelSubscription-Based58.03% · USD 4.41 billion
End userIndividual and Consumer63.95% · USD 4.86 billionEnterprise and Employers 15.49%
Age groupAdults68.03% · USD 5.17 billionAdolescents and Teenagers 15.02%
  • North America was the largest region in 2025, holding 40% of global revenue at USD 3.04 billion and reaching USD 7.83 billion by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 21.97% in 2025 to 27% in 2034, with revenue growing from USD 1.67 billion to USD 6.41 billion.
  • Middle East and Africa remains the smallest region throughout, at 6.05% of 2025 revenue and 9.02% by 2034.
  • Depression and Anxiety Management was the leading application type line in 2025, taking 33.95% of revenue at USD 2.58 billion.
  • Stress Management is projected to grow at 14.4% over the forecast period, the fastest of any application type line.
  • The United States is the largest single country market at USD 2.68 billion in 2025, 35.26% of global revenue.

The report segments the market across five axes; by application type, and by platform type, business model, end user and age group; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 20.42 billion and USD 28.01 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078